FreeTheAI

Alumis Inc.

ALMS · NASDAQ · USD

$6.97

+0.20 2.95%todayNot financial advice.

ALMS Price chart 6M
Open
6.66
Day range
6.61 - 7.02
52-week range
4.28 - 31.35
Volume
2.85M
Market cap
930.46M
P/E ratio
—
EPS
-3.81
Dividend yield
0.00%
Beta
1.04

Performance

W

−5.81%

1M

−36.92%

3M

−76.95%

6M

−69.75%

YTD

−28.66%

Y

+52.85%

5Y

−48.37%

All

−48.37%

In the news

  1. Oct 9

    Alumis Reports Positive Phase 3 Psoriasis Data, Plans NDA Submission in Late 2026

    Alumis Inc. reported positive Phase 3 data for its psoriasis drug envudeucitinib and remains on track to submit a marketing application in late 2026.

    Company news

  2. Oct 9

    Alumis Phase 3 Data Shows Envudeucitinib Durably Improves Plaque Psoriasis Symptoms

    Alumis Inc. released positive Phase 3 data for its oral psoriasis drug envudeucitinib, paving the way for a regulatory filing in late 2026.

    Company news

Embed on your site

Embed docs

Add a live price card or a chart to any page. Free, no sign-up; cards refresh every minute and link back here.

<iframe src="https://stocks.freetheai.org/embed/NASDAQ-ALMS" width="340" height="170" style="border:0;max-width:100%" loading="lazy" title="Alumis Inc. (ALMS) - FreeTheAI Stocks"></iframe>
<p style="font-size:12px"><a href="https://stocks.freetheai.org/symbols/NASDAQ-ALMS">ALMS stock price</a> by FreeTheAI Stocks</p>